SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bernhard J. Steinhoff, Klaus Eckhardt, Pamela Doty, Marc De Backer, Marcus Brunnert, Andreas Schulze-Bonhage, A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures, Epilepsy & Behavior, 2016, 58, 35

    CrossRef

  2. 2
    I. N. Vakula, E. O. Bojko, U. A. Vorona, J. A. Storozhuk, E. U. Nikiforova, D. I. Nikiforova, T. I. Glazunova, The efficacy of intravenous lacosamide in psychiatric hospital, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2016, 116, 2, 67

    CrossRef

  3. 3
    Willi Cawello, Clinical Pharmacokinetic and Pharmacodynamic Profile of Lacosamide, Clinical Pharmacokinetics, 2015, 54, 9, 901

    CrossRef

  4. 4
    Lesley J. Scott, Lacosamide: A Review in Focal Seizures in Patients with Epilepsy, Drugs, 2015, 75, 18, 2143

    CrossRef

  5. 5
    R. Eugene Ramsay, Vivek Sabharwal, Fawad Khan, Hina Dave, Cyrus Kafai, Rachel Shumate, Megan Irland, Safety & pK of IV loading dose of lacosamide in the ICU, Epilepsy & Behavior, 2015, 49, 340

    CrossRef

  6. 6
    Brian Spoelhof, Lynn Frendak, Lucia Rivera Lara, A worldwide yearly survey of new data in adverse drug reactions, 2015,

    CrossRef

  7. 7
    Linda J. Stephen, Kevin Kelly, Pamela Parker, Martin J. Brodie, Adjunctive lacosamide—5 Years’ clinical experience, Epilepsy Research, 2014, 108, 8, 1385

    CrossRef

  8. 8
    Willi Cawello, Armel Stockis, Jens-Otto Andreas, Svetlana Dimova, Advances in epilepsy treatment: lacosamide pharmacokinetic profile, Annals of the New York Academy of Sciences, 2014, 1329, 1
  9. 9
    C. Kellinghaus, S. Berning, F. Stögbauer, Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus, Acta Neurologica Scandinavica, 2014, 129, 5
  10. 10
    Stefano de Biase, Gian Luigi Gigli, Mariarosaria Valente, Giovanni Merlino, Lacosamide for the treatment of epilepsy, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 3, 459

    CrossRef

  11. 11
    Russell C Bailey, Nathan B Fountain, Update on the use of lacosamide in the treatment of partial-onset seizures, Future Neurology, 2014, 9, 3, 301

    CrossRef

  12. 12
    Pamela Doty, David Hebert, Francois-Xavier Mathy, William Byrnes, James Zackheim, Kelly Simontacchi, Development of lacosamide for the treatment of partial-onset seizures, Annals of the New York Academy of Sciences, 2013, 1291, 1
  13. 13
    Sheridan M. Hoy, Lacosamide: A Review of Its Use as Adjunctive Therapy in the Management of Partial-Onset Seizures, CNS Drugs, 2013, 27, 12, 1125

    CrossRef

  14. 14
    William O. Tatum, Recent and Emerging Anti-seizure Drugs: 2013, Current Treatment Options in Neurology, 2013, 15, 4, 505

    CrossRef

  15. 15
    Aatif M. Husain, Treatment of Recurrent Electrographic Nonconvulsive Seizures (TRENdS) Study, Epilepsia, 2013, 54,
  16. 16
    Marcia L. Buck, Howard P. Goodkin, Use of Lacosamide in Children with Refractory Epilepsy, The Journal of Pediatric Pharmacology and Therapeutics, 2012, 17, 3, 211

    CrossRef